Cargando…
Clinical Predictors of Response to Tocilizumab: A Retrospective Multicenter Study
OBJECTIVE: A substantial number of patients with coronavirus disease-2019 (COVID-19) demonstrate severe infection. Cytokine storm is an underlying condition that worsens clinical outcomes. As an interleukin-6 receptor antagonist, tocilizumab is a promising treatment option for COVID-19. This study a...
Autores principales: | Ercan, Selin, Ergan, Begüm, Selin Özuygur, Saliha, Korkmaz, Pervin, Sezai Taşbakan, Mehmet, Basoglu, Özen K., Kerget, Buğra, Akgün, Metin, Elbek, Osman, Sayıner, Abdullah, Kılınç, Oğuz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Thoracic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450267/ https://www.ncbi.nlm.nih.gov/pubmed/35579229 http://dx.doi.org/10.5152/TurkThoracJ.2022.21179 |
Ejemplares similares
-
Treatment of SARS-CoV-2 pneumonia with favipiravir: early results from the Ege University cohort, Turkey
por: ERDEM, Hüseyin Aytaç, et al.
Publicado: (2021) -
Pneumonia severity indices predict prognosis in coronavirus disease-2019
por: Ucan, E.S., et al.
Publicado: (2021) -
Evaluation of Periorbital Tissues in Obstructive Sleep Apnea Syndrome
por: Karaca, Irmak, et al.
Publicado: (2020) -
Interference in scientific research on COVID-19 in Turkey
por: Bayram, Hasan, et al.
Publicado: (2020) -
A Clinical Prediction Formula for Apnea-Hypopnea Index
por: Sahin, Mustafa, et al.
Publicado: (2014)